MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0018630
Lilyford Pharma Private Limited
Lilyford Pharma Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹8.22 Lakh
▼ 11% YoY
Net loss · FY 2026
₹38,021
Net margin -4.6%
EBITDA · FY 2026
-₹37,372
EBITDA margin -4.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Lilyford Pharma Private Limited
Data last updated:
Lilyford Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 05 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2015PTC281176.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harpreet Kaur and Manish Kumar Agarwal.
Its last annual general meeting (AGM) was held on 09 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ga/4. 1st Floor Street 4 Block G Hari Nagar, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2026, the company reported a revenue of ₹8.22 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹38,021 (net margin -4.6%) and EBITDA of -₹37,372 (EBITDA margin -4.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 22% over five years.
Lilyford Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0018630). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Lilyford Pharma Private Limited
CIN U24233DL2015PTC281176
Registration Number 281176
Incorporation Date 05 June 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 09 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0018630
Recognitions & Rankings of Lilyford Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGa/4. 1st Floor Street 4 Block G Hari Nagar, New Delhi, Delhi, India – 110058
- IndustryHealthcare, Other Hospital And Medical Care Activities
Comprehensive company report
Lilyford Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Lilyford Pharma Private Limited
The main business activity of Lilyford Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lilyford Pharma Private Limited FY 2025 filings available
Lilyford Pharma Private Limited reported revenue of ₹8.22 Lakh (down 11% YoY) for FY 2026.
Revenue · FY 2026
₹8.22 Lakh ▼ 11%
Net loss · FY 2026
₹38,021 margin -4.6%
EBITDA · FY 2026
-₹37,372 margin -4.5%
Compounded Annual Growth Rate (CAGR) of Lilyford Pharma Private Limited
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 11%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 74%
3 years · compounded
▼ 26%
5 years · compounded
▲ 27%
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lilyford Pharma Private Limited
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹37,372 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹38,021 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lilyford Pharma Private Limited
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lilyford Pharma are in the company report.
Premium access
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Lilyford Pharma Private Limited
Lilyford Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harpreet Kaur | Director | 15 Mar 2017 | 9 Years 7 Months | Current |
| Manish Kumar Agarwal | Director | 15 Mar 2017 | 9 Years 7 Months | Current |
Peer Comparison of Lilyford Pharma Private Limited
Lilyford Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Human health activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Modern Homeopathy Clinics Private Limited | ₹9.31 Lakh (FY 2025) | •••• | •••• | -37.0% | •••• | Kolhapur, Maharashtra, India |
| Sainiwas Charitable Foundation | ₹9.31 Lakh (FY 2025) | •••• | •••• | 97.0% | •••• | New Delhi, Delhi, India |
| Orpin International Private Limited | ₹9.31 Lakh (FY 2025) | •••• | •••• | 55.0% | •••• | Moradabad, Uttar Pradesh, India |
| 4Leg Care Foundation | ₹9.28 Lakh (FY 2025) | •••• | •••• | 155.0% | •••• | Alwar, Rajasthan, India |
| Ubique Pharma Private Limited | ₹9.26 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Rajganj, West Bengal, India |
| Bhojak Hospitals Private Limited | ₹9.2 Lakh (FY 2025) | •••• | •••• | -86.0% | •••• | Churu, Rajasthan, India |
| Healthcure Pharmaceutical Private Limited | ₹9.17 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Delhi, India |
| Aavinya Medicare Private Limited | ₹9.17 Lakh (FY 2025) | •••• | •••• | 89.0% | •••• | Jalgaon, Maharashtra, India |
| Pari Pathology Private Limited | ₹9.14 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Bhopal, Madhya Pradesh, India |
| All India Bright Vision Foundation | ₹9.13 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Lilyford Pharma Private Limited this company | ₹8.22 Lakh (FY 2026) | •••• | •••• | -11.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Lilyford Pharma by revenue in the same principal business activity (Human health activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Lilyford Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lilyford Pharma Private Limited
Lilyford Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lilyford Pharma Private Limited
Employment history and EPFO contributions of people linked to Lilyford Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lilyford Pharma Private Limited
Lilyford Pharma Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Harpreet Kaur ceased to be Additional Director on 29 Sep 2017.
AGM
Lilyford Pharma Private Limited last Annual general meeting of members was held on 09 Aug 2025 as per latest MCA records.
Filing
Lilyford Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Harpreet Kaur ceased to be Additional Director.
Ceased
Manish Kumar Agarwal ceased to be Additional Director.
Ceased
Reena Agarwal ceased to be Director.
Ceased
Sunil Agarwal ceased to be Director.
Appointed
Harpreet Kaur was appointed as Director.
Appointed
Manish Kumar Agarwal was appointed as Director.
Incorporation
05 Jun 2015
Lilyford Pharma Private Limited was registered on 05 Jun 2015 with Roc Delhi I & aged 11 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Lilyford Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lilyford Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lilyford Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lilyford Pharma Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lilyford Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lilyford Pharma Private Limited
Lilyford Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 05 June 2015 (11+ years old) and is registered under CIN U24233DL2015PTC281176.
Lilyford Pharma reported revenue of ₹8.22 Lakh for FY 2026 (down 11% YoY).
Lilyford Pharma has 2 current directors:
- Harpreet Kaur - Director
- Manish Kumar Agarwal - Director
Lilyford Pharma reported a net loss of ₹38,021 (net margin -4.6%) and EBITDA of -₹37,372 (EBITDA margin -4.5%) for FY 2026, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lilyford Pharma is 11% over three years and 22% over five years. In the latest year (FY 2026) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Lilyford Pharma is U24233DL2015PTC281176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lilyford Pharma was incorporated on 05 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lilyford Pharma by revenue are Modern Homeopathy Clinics Private Limited, Sainiwas Charitable Foundation, Orpin International Private Limited, 4Leg Care Foundation, Ubique Pharma Private Limited and 5 more, all in the same principal business activity (Human health activities).
Harpreet Kaur ceased to be Additional Director on 29 Sep 2017. Manish Kumar Agarwal ceased to be Additional Director on 29 Sep 2017. Reena Agarwal ceased to be Director on 16 Mar 2017. Lilyford Pharma has 6 board changes on record in total.
Yes, Lilyford Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0018630).
The registered office of Lilyford Pharma is at Ga4. 1st Floor Street 4 Block G Hari Nagar, New Delhi, Delhi, India – 110058.